Changes in symptom burden and quality of life among women with uterine fibroids receiving relugolix combination therapy: a plain language summary

Abstract

This is a summary of findings from two research studies (known as clinical trials). The studies looked at how well a medicine called relugolix combination therapy worked in women with heavy menstrual bleeding (heavy bleeding during a period) with uterine fibroids (noncancerous or benign growths in the uterus). In this analysis of the studies, researchers looked at how patients self-reported their uterine fibroid symptoms before and after taking relugolix combination therapy. Researchers also looked at how patients self-reported the impact of uterine fibroids on their health-related quality of life before and after taking relugolix combination therapy.

Keywords

• heavy menstrual bleeding
• lay summary
• plain language summary
• quality of life
• symptom burden
• uterine fibroids
• women's health